- PrescribeIT® is a national e-prescription network
spear-headed by the Federal Government's Canada Health
Infoway.
- WELL has fully integrated PrescribeIT® within its
OSCAR Pro EMR allowing participating physicians and clinicians to
leverage the growing e-prescription ecosystem across Canada.
This service is now operational and available for immediate
use.
- PrescribeIT® enables prescribers and pharmacists to
electronically create, receive, renew and cancel prescriptions,
while improving overall patient care through secure clinician
messaging.
- PrescribeIT® joins the growing list of integrated
applications and services profiled through WELL Health's
apps.health marketplace.
VANCOUVER, BC and TORONTO, Dec. 11,
2020 /CNW/ - WELL Health Technologies Corp.
(TSX.V: WELL) (the "Company" or "WELL"), a company
focused on consolidating and modernizing clinical and digital
assets within the primary health care sector, is pleased to
announce it has partnered with Canada Health Infoway
("Infoway") to integrate Infoway's national e-prescribing
service, PrescribeIT®, with WELL's OSCAR Pro
Electronic Medical Records (EMR) software. Physicians and
health care practitioners using OSCAR Pro are now able to easily
create, renew and cancel prescriptions electronically, while
improving overall patient care through secure clinician messaging.
WELL is offering an end-to-end solution from virtual and on-site
patient consultation to electronic prescription, resulting in a
better physician and patient experience. By partnering with
PrescribeIT®, health care practitioners, pharmacists and
patients can have confidence that the solution ensures patient
privacy and security of information.
"We are very excited to launch our e-prescribing service with
Infoway's PrescribeIT®," said Hamed Shahbazi, Chairman and CEO of WELL.
"Electronic prescriptions will be a key for making virtual visits
more efficient and effective, and this integration with the WELL
EMR network can help create a better patient experience. I am very
proud of our WELL EMR Group who has worked tirelessly to
successfully achieve conformance approval from Infoway and our WELL
Digital Health Apps team who have made the service available
through the apps.health marketplace."
PrescribeIT® enhances clinical communications,
e-renewals, privacy and security. Prescriptions can now be
sent directly from within OSCAR Pro EMR in a secure electronic
format to the patient's pharmacy of choice and pharmacies can
electronically request prescription renewals from the patient's
health care provider. Electronic prescriptions are key for virtual
visits as the patient does not have to rely on faxing prescriptions
to pharmacies. Furthermore, patient safety is increased due to
prevention of data entry errors at the pharmacy and prescription
fraud is decreased through direct transmission of the
prescription from the prescriber to the pharmacy through the
PrescribeIT® service.
"We are excited about this partnership with WELL to make
PrescribeIT® available to prescribers who use the OSCAR
Pro EMR software," said Jamie Bruce,
Executive Vice President, Infoway. "PrescribeIT® makes
prescribing safer, more secure, easier and more convenient.
PrescribeIT® is also an increasingly important tool in
the prescriber's virtual care toolbox."
WELL Health Technologies Corp.
Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL
WELL is an omni-channel digital health company whose overarching
objective is to empower doctors to provide the best and most
advanced care possible while leveraging the latest trends in
digital health. As such, WELL owns and operates 25 primary health
care clinics, is Canada's third
largest digital Electronic Medical Records (EMR) supplier serving
over 2,000 medical clinics, operates a leading national telehealth
service and is a provider of digital health, billing and
cybersecurity related technology solutions. WELL is an acquisitive
company that follows a disciplined and accretive capital allocation
strategy. WELL is publicly traded on the Toronto Stock Exchange
under the symbol "WELL" and the Company was recognized as a TSX
Venture 50 Company three years in a row in 2018, 2019 and 2020. To
access the Company's telehealth service, visit:
tiahealth.com or virtualclinics.ca and for corporate
information, visit: www.well.company.
About Canada Health Infoway
Infoway helps to improve the health of Canadians by working with
partners to accelerate the development, adoption and effective use
of digital health across Canada.
Through our investments, we help deliver better quality and access
to care and more efficient delivery of health services for patients
and clinicians. Infoway is an independent, not-for-profit
organization funded by the federal government.
Visit www.infoway-inforoute.ca.
About PrescribeIT®
Canada Health Infoway is working with Health Canada, the
provinces and territories, and industry stakeholders to develop,
operate and maintain the national e-prescribing service known as
PrescribeIT®. PrescribeIT® will serve
all Canadians, pharmacies and prescribers and provide safer and
more effective medication management by enabling prescribers to
transmit a prescription electronically between a prescriber's
electronic medical record (EMR) and the pharmacy management system
(PMS) of a patient's pharmacy of choice.
PrescribeIT® will protect Canadians' personal
health information from being sold or used for commercial
activities. Visit www.PrescribeIT.ca.
Forward-Looking Statements
This news release may contain "forward-looking statements"
within the meaning of applicable Canadian securities laws,
including, without limitation statements regarding: improvement to
overall patient care through clinical messaging; and the belief
that the launch will ensure patient privacy and security of
information. Forward-looking statements are necessarily based upon
a number of estimates and assumptions that, while considered
reasonable by management, are inherently subject to significant
business, economic and competitive uncertainties, and
contingencies. These statements generally can be identified by the
use of forward-looking words such as "may", "should", "will",
"could", "intend", "estimate", "plan", "anticipate", "expect",
"believe" or "continue", or the negative thereof or similar
variations. Forward-looking statements involve known and unknown
risks, uncertainties and other factors that may cause future
results, performance or achievements to be materially different
from the estimated future results, performance or achievements
expressed or implied by those forward-looking statements and the
forward-looking statements are not guarantees of future
performance. WELL's statements expressed or implied by these
forward-looking statements are subject to a number of risks,
uncertainties, and conditions, many of which are outside of WELL 's
control, and undue reliance should not be placed on such
statements. Forward-looking statements are qualified in their
entirety by inherent risks and uncertainties, including: risks
related to privacy and cyber security concerns; risks related to
compatibility between the two platforms and solutions; and error
free adoption, use and growth of the service. Except as required by
securities law, WELL does not assume any obligation to update or
revise any forward-looking statements, whether as a result of new
information, events or otherwise.
Neither the TSX nor its Regulation Services Provider (as that
term is defined in policies of the TSX) accepts responsibility for
the adequacy or accuracy of this release.
For further information:
Pardeep S. Sangha
VP
Corporate Strategy and Investor Relations
WELL Health Technologies Corp.
investor@well.company
604.572.6392
Karen Schmidt
Director, Corporate/Internal Communications
Canada Health Infoway
416.886.4967
Email Us
Follow @Infoway
Inquiries about PrescribeIT®
Tania Ensor
Senior Director, Marketing, Stakeholder Relations and Reputation
Management, PrescribeIT®
Canada Health Infoway
416.707.6285
PrescribeIT@Infoway-Inforoute.ca
Follow @PrescribeIT_CA
SOURCE WELL Health Technologies Corp.